⏳ Fetching live dividend data...
Home › Calculator › AVTE Dividend Calculator 2026
Aerovate Therapeutics, Inc. · NASDAQ
Price: $2.68 · Annual div: $2.40/share · Frequency: quarterly · Payout ratio: N/A · Ex-div: 2025-04-29
AVTE (Aerovate Therapeutics, Inc.) has a dividend yield of 89.55%, based on an annual dividend of $2.40 per share and a price of $2.68. Over the last 12 months it paid $0.0000 per share — a trailing yield of 0.00%.
At a 89.55% yield, reinvesting every payout is not a realistic long-term assumption — payouts this high rarely last and the share price usually falls as they are paid, so we don't model DRIP growth for AVTE.
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2025-04-29Latest | — | $2.4000 | 2.73% | $87.85 |
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across the United States. The company's principal effort involves advancing AV-101, an inhaled dry powder variant of imatinib, which is currently undergoing a Phase 2b/Phase 3 clinical study for the management of pulmonary arterial hypertension. Established in 2018, Aerovate Therapeutics, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
AVTE (Aerovate Therapeutics, Inc.) has a dividend yield of 89.55%, based on an annual dividend of $2.40 per share and a price of $2.68. Over the last 12 months it paid $0.0000 per share — a trailing yield of 0.00%.
$10,000 in AVTE at a 89.55% yield pays about $8,955 a year ($746 a month) before taxes. Payouts this high rarely last — don't count on this income continuing at today's rate.
At a 89.55% yield, reinvesting every payout is not a realistic long-term assumption — payouts this high rarely last and the share price usually falls as they are paid, so we don't model DRIP growth for AVTE.
Enter your starting amount, monthly contribution and time horizon in the AVTE DRIP calculator at the top of this page. It reinvests each payout into new shares at the projected price, grows the dividend at the rate you choose and shows yearly income, share count, portfolio value and yield on cost. You can switch DRIP off to compare.
AVTE's next ex-dividend date has not been announced yet; the most recent one was 2025-04-29. Buy before the ex-dividend date to receive the next payment.
AVTE has less than a year of dividend history in our data, so there is no dividend growth rate yet.
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open AVTE position with:
Real after-tax yield depends on where you live and how you hold AVTE.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 89.55% | 86.75% | $8,955 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 76.12% | 73.32% | $7,612 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 71.64% | 68.84% | $7,164 / yr |
| 🇬🇧 UK ISA | 0% | 89.55% | 86.75% | $8,955 / yr |
| 🇬🇧 UK Taxable | 8.75% | 81.71% | 78.91% | $8,171 / yr |
| 🇨🇦 TFSA | 0% | 89.55% | 86.75% | $8,955 / yr |
| 🇨🇦 CA Taxable | 25% | 67.16% | 64.36% | $6,716 / yr |
| 🇦🇺 Super (pension) | 15% | 76.12% | 73.32% | $7,612 / yr |
| 🇦🇺 AU Taxable | 30% | 62.68% | 59.88% | $6,268 / yr |
| 🇩🇪 DE Taxable | 26.375% | 65.93% | 63.13% | $6,593 / yr |
| 🇫🇷 FR Taxable | 30% | 62.68% | 59.88% | $6,268 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.40/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
AVTE pays quarterly — 4 times per year. Ex-div: 2025-04-29.
How AVTE compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for AVTE sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2024-08-01 | 1,507 | $1.74 | $2.6K | ||
| M-Exempt | 2024-07-31 | 11,454 | $1.74 | $19.9K | ||
| M-Exempt | 2024-07-31 | 10,548 | $1.74 | $18.4K | ||
| M-Exempt | 2024-08-01 | 1,507 | $1.74 | $2.6K | ||
| Buy | 2024-06-17 | 928,110 | $1.67 | $1.55M | ||
| M-Exempt | 2024-06-14 | 15,000 | $2.14 | $32.1K | ||
| M-Exempt | 2024-06-14 | 15,000 | $2.14 | $32.1K | ||
| Sale | 2024-06-14 | 15,000 | $25.03 | $375.4K | ||
| M-Exempt | 2024-06-14 | 10,600 | $14.59 | $154.7K | ||
| M-Exempt | 2024-06-14 | 10,600 | $14.59 | $154.7K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Compare AVTE with peers: AVTE vs ACHL · AVTE vs BLI · AVTE vs IGMS
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the AVTE dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Aerovate Therapeutics, Inc. (AVTE) is currently trading at $2.68, trading near its 52-week low. The current dividend yield is 89.55% based on an annual payout of $2.40 per share.
Aerovate Therapeutics, Inc. (AVTE) is a healthcare stock currently trading at $2.68 with a dividend yield of 89.55%. It pays an annual dividend of $2.40 per share.
Auto-generated from live market data. For educational purposes only — not financial advice.
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.
Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.
I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.
Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.
As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.
The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.
For educational purposes only. Not financial advice.
Share your real experience on Trustpilot →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever